IBS Logo Primary.jpg
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
28 juin 2024 08h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
IBS Logo Primary.jpg
Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
27 juin 2024 08h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
psychemdicslogo.jpg
Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
21 juin 2024 10h00 HE | Psychemedics Corporation
Psychemedics Corporation releases its inaugural 2024 Insights Report, offering a comprehensive analysis of workplace drug trends from 2023.
IBS Logo Primary.jpg
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
18 juin 2024 08h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
clearstar-300dpi.png
ClearStar Announces Appointment of Pam Dunsky as Chief Operating Officer
28 févr. 2024 10h47 HE | ClearStar
ClearStar appoints Pam Dunsky as Chief Operating Officer (COO) to oversee Client Service and Operations.
Global Mice Model Market
Expanding Mice Model Market Propels Life Sciences Research, Forecasts a Surge to $2.54 Billion by 2030
24 janv. 2024 11h07 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Mice Model Market by Service (Breeding, Cryopreservation, Genetic Testing), Type (Conditioned/Surgically Modified Mice, Genetically Engineered...
22157.jpg
United States Humanized Mice Model Research Report 2023: Markets, Competition, Forecast and Opportunities, 2018-2028
24 nov. 2023 10h18 HE | Research and Markets
Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "United States Humanized Mice Model Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
ClearStar announces
ClearStar announces appointment of Mike Pritts as Chief Executive Officer
03 nov. 2023 16h50 HE | ClearStar
Alpharetta, Georgia, Nov. 03, 2023 (GLOBE NEWSWIRE) -- ClearStar, Inc., a leading provider of modern, integrated, background, drug, and health screening solutions, is pleased to announce the...
website-logo (2).png
Drug Testing Market Projected to Grow at 6.8% CAGR, Crossing US$ 13.3 Billion by 2032, Reports Marketresearch.biz
31 oct. 2023 07h32 HE | MarketResearch.biz
New York, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The global drug testing market is poised for significant growth and is expected to be worth USD 13.3 billion by 2032, from USD 7.0 billion in 2022,...
psychemdicslogo.jpg
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
27 oct. 2023 11h00 HE | Psychemedics Corporation
Psychemedics debuts a 5-panel drug test replacing marijuana with fentanyl, the first hair drug test exclusively targeting the most dire workplace threats.